BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE

July 13, 2001

Slides

Responses to FDA Gene Therapy Letter: Adenovirus Vector Titer Measurements and RCA Levels, Steven R Bauer, PhD, FDA   ppt   html

Overview of Adenoviral Vectors and Titer Determination, C Estuardo Aguilar-Cordova, MD, Harvard University   ppt   html

RCA Assays and Clinical Data For a rAD-p53 in Cancer Patients, Beth Hutchins, PhD, Canji, Inc.   ppt   html

Absence of RCA Isolated from Patients Treated with INGN 201 (Ad5CMV-p53), Richard Sublett, PhD, Introgen Therapeutics   ppt   html

Adenovirus Infections in Immunocompromised Hosts, Phyllis Flomenberg, MD, Thomas Jefferson University   ppt   html